FDx Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,206
| Closed | -$311K | – | 448 |
|
|
2023
Q4 | $311K | Sell |
4,206
-520
| -11% | -$38.5K | 0.02% | 520 |
|
|
2023
Q3 | $322K | Sell |
4,726
-4,601
| -49% | -$313K | 0.03% | 451 |
|
|
2023
Q2 | $876K | Sell |
9,327
-7,497
| -45% | -$704K | 0.05% | 331 |
|
|
2023
Q1 | $833K | Hold |
16,824
| – | – | 0.04% | 332 |
|
|
2022
Q4 | $833K | Buy |
16,824
+3,658
| +28% | +$181K | 0.04% | 332 |
|
|
2022
Q3 | $428K | Sell |
13,166
-530
| -4% | -$17.2K | 0.02% | 443 |
|
|
2022
Q2 | $539K | Sell |
13,696
-414
| -3% | -$16.3K | 0.02% | 456 |
|
|
2022
Q1 | $987K | Buy |
14,110
+4,087
| +41% | +$286K | 0.03% | 329 |
|
|
2021
Q4 | $780K | Buy |
10,023
+788
| +9% | +$61.3K | 0.02% | 417 |
|
|
2021
Q3 | $881K | Buy |
9,235
+1,301
| +16% | +$124K | 0.03% | 364 |
|
|
2021
Q2 | $986K | Buy |
7,934
+1,415
| +22% | +$176K | 0.03% | 340 |
|
|
2021
Q1 | $859K | Buy |
6,519
+1,054
| +19% | +$139K | 0.03% | 328 |
|
|
2020
Q4 | $724K | Buy |
+5,465
| New | +$724K | 0.03% | 347 |
|
|
2020
Q1 | – | Sell |
-3,912
| Closed | -$362K | – | 554 |
|
|
2019
Q4 | $362K | Buy |
3,912
+302
| +8% | +$27.9K | 0.02% | 435 |
|
|
2019
Q3 | $326K | Buy |
+3,610
| New | +$326K | 0.02% | 456 |
|
|
2017
Q2 | – | Sell |
-12,631
| Closed | -$298K | – | 1199 |
|
|
2017
Q1 | $298K | Sell |
12,631
-2,173
| -15% | -$51.3K | 0.01% | 974 |
|
|
2016
Q4 | $198K | Buy |
14,804
+1,858
| +14% | +$24.9K | 0.01% | 1087 |
|
|
2016
Q3 | $240K | Buy |
+12,946
| New | +$240K | 0.01% | 831 |
|